Explore the words cloud of the PRISAR2 project. It provides you a very rough idea of what is the project "PRISAR2" about.
The following table provides information about the project.
|Coordinator Country||Netherlands [NL]|
|Total cost||2˙484˙000 €|
|EC max contribution||2˙484˙000 € (100%)|
1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
|Duration (year-month-day)||from 2020-04-01 to 2024-03-31|
Take a look of project's partnership.
|1||PERCUROS BV||NL (LEIDEN)||coordinator||331˙200.00|
|2||CHIPDX IVS||DK (VAERLOSE)||participant||165˙600.00|
|3||HEINRICH-HEINE-UNIVERSITAET DUESSELDORF||DE (DUSSELDORF)||participant||165˙600.00|
|4||TECHNICKA UNIVERZITA VO ZVOLENE||SK (ZVOLEN)||participant||165˙600.00|
|5||UNIVERSITAETSMEDIZIN GOETTINGEN - GEORG-AUGUST-UNIVERSITAET GOETTINGEN - STIFTUNG OEFFENTLICHEN RECHTS||DE (GOETTINGEN)||participant||138˙000.00|
|6||ASSOCIAZIONE TOURISM||IT (NEMI)||participant||124˙200.00|
|7||ACADEMISCH ZIEKENHUIS LEIDEN||NL (LEIDEN)||participant||110˙400.00|
|8||TACIT BIO INNOVATION LIMITED||UK (SUTTON COLDFIELD)||participant||110˙400.00|
|9||TECOBIOSCIENCES GMBH||DE (LANDSHUT)||participant||110˙400.00|
|10||UNIVERSITA DEGLI STUDI DI CAMERINO||IT (CAMERINO)||participant||110˙400.00|
|11||UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II||IT (NAPOLI)||participant||110˙400.00|
|12||DATAR CANCER GENETICS (EUROPE) GMBH||DE (ECKERSDORF)||participant||101˙200.00|
|13||PROGREDUM GMBH||DE (KAISERSLAUTERN)||participant||92˙000.00|
|14||DES SOLUTIO - SOLUCOES E CONSULTORIA CIENTIFICA LDA||PT (CHARNECA DE CAPARICA)||participant||82˙800.00|
|15||ASSOCIAZIONE HAND IN HAND||IT (NEMI)||participant||69˙000.00|
|16||ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM||NL (ROTTERDAM)||participant||55˙200.00|
|17||FUJIFILM SONOSITE BV||NL (AMSTERDAM)||participant||55˙200.00|
|18||NEMI TERRITORIO E TURISMO||IT (NEMI)||participant||55˙200.00|
|19||SERANOVO BV||NL (LEIDEN)||participant||55˙200.00|
|20||SURGIMAB SAS||FR (MONTPELLIER)||participant||55˙200.00|
|21||THE UNIVERSITY OF EDINBURGH||UK (EDINBURGH)||participant||55˙200.00|
|22||THE UNIVERSITY OF SHEFFIELD||UK (SHEFFIELD)||participant||55˙200.00|
|23||UNIVERSITE DE STRASBOURG||FR (STRASBOURG)||participant||55˙200.00|
|24||HAMMERSMITH MEDICINES RESEARCH LTD||UK (LONDON)||participant||27˙600.00|
|25||THE UNIVERSITY OF LIVERPOOL||UK (LIVERPOOL)||participant||27˙600.00|
From 2016 -2019, the “first” PRISAR consortium implemented the first Dutch RISE project of H2020 to investigate the use of imaging technologies and hybrid fluorescence/radionuclide probes for the surgical intervention of cancer. This PRISAR project provided a career-enabling human resource plethora of inter-disciplinary and inter-sectoral secondments, which resulted in the development, of not only a hybrid probe for image-guided surgery, but also a variety of tools and instruments. We now propose a new project, PRISAR2, to implement the next logical phase of this work, which is to clinically translate new and innovative monitoring technologies from industry. This will provide better patient selection and increase the surveillance window to allow for better treatment options over time and avoid surgery. This will involve developing new ‘watch and wait’ strategies to study the behaviour of the cancer so that any risks can be minimized. This would lead to a better clinical outcome and quality of life (QOL) for the patient and maximize the benefits of an active monitoring policy for both the patient and the healthcare system. When a patient is discovered to have cancer, one of the primary goals is to have the tumour removed by surgery. Here, however, we aim to (a) develop new monitoring technologies from industry so that the surveillance window can be increased to allow for better treatment options over time and to avoid surgery, (b) develop new ‘watch and wait’ strategies in order to study the behaviour of the cancer so that any risks to the patient can be minimised leading to a better clinical outcome and (c) train a new generation of preclinical and clinical scientists to be able to implement this new concept as standard of care and to maximise the benefits of an active monitoring policy.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PRISAR2" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "PRISAR2" are provided by the European Opendata Portal: CORDIS opendata.
Ultra-Dense Unsupervised Heterogeneous Wireless Cloud Coded Networks for 5G/B5GRead More
Addressing inequality, enhancing diversity and facilitating greater dialogue in the hosting of sporting mega events.Read More
Addressing Verification and Validation Challenges in Future Cyber-Physical SystemsRead More